A gonadotropin-releasing hormone agonist versus a continuous oral contraceptive pill in the treatment of bladder endometriosis

Luigi Fedele, Stefano Bianchi, Sarah Montefusco, Giada Frontino, Luca Carmignani
Fertility and sterility · 2008 · vol. 90(1) , pp. 183–184 · doi:10.1016/j.fertnstert.2007.09.060 · PMID:18177868 · W2086170014
article OA: bronze CC0 ⤵ 35 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study compared the efficacy of a gonadotropin-releasing hormone agonist to a continuous oral contraceptive pill for treating bladder endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosisbladder_endometriosis

MeSH descriptors

Contraceptives, Oral Endometriosis Gonadotropin-Releasing Hormone Urinary Bladder Urinary Bladder Diseases Contraceptives, Oral Endometriosis Endometriosis Female Gonadotropin-Releasing Hormone Humans Prospective Studies Time Factors Treatment Outcome Urinary Bladder Urinary Bladder Urinary Bladder Diseases Urinary Bladder Diseases

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (2)

Cited by (35)

Source provenance

europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:14:42.556217+00:00
License: CC0 · commercial use OK